BAY85-3934
| CAS No. | 1154028-82-6 | Cat. No. | BCP14477 |
| Name | BAY85-3934 | ||
| Synonyms | Molidustat;BAY 85-3934;BAY-85-3934; BAY 853934; BAY-853934; BAY853934; | ||
| Formula | C13H14N8O2 | M. Wt | 314.3 |
| Description | Molidustat, also known as BAY 85-3934, is a novel inhibitor of hypoxia-inducible factor (HIF) prolyl hydroxylase (PH) which stimulates erythropoietin (EPO) production and the formation of red blood cells. Phase I data have shown that inhibition of HIF-PH by Molidustat results in an increase in endogenous production of EPO. Molidustat is currently clinical trials at Bayer for the treatment of patients suffering from renal anemia due to chronic kidney disease. | ||
| Pathways | Angiogenesis/Protein Tyrosine Kinase | ||
| Targets | HIF | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.